Integrating urinary and plasma omics to identify markers and therapeutic targets for cardiac disease
de Ruiter, S. C.; van Vugt, M.; Finan, C.; Providencia, R.; Chopade, S.; Grobbee, D. E.; den Ruijter, H. M.; Peters, S. A. E.; Schmidt, A. F.
Show abstract
IntroductionUrinary breakdown products, representing kidney regulated filtration of metabolism end products, contain cardiac disease biomarkers such as NT-proBNP. We set out to integrate plasma proteins with metabolism pathways, as reflected by urinary breakdown products, to identify potentially druggable metabolism pathways for cardiac disease. MethodsData was leveraged from a genome-wide association study (GWAS) on 954 urinary breakdown products. Mendelian randomisation was used to identify urinary breakdown products associating with atrial fibrillation (AF), heart failure (HF), dilated cardiomyopathy (DCM), or hypertrophic cardiomyopathy (HCM). By interrogating eight independent plasma protein GWAS, jointly including 92,277 participants and 1,562 unique proteins, we identified druggable plasma proteins with a directionally concordant effect on urinary breakdown products and cardiac outcomes. ResultsIn total, 38 unique urinary breakdown products associated with cardiac disease, predominantly covering breakdown products from amino acid metabolism (n=12), xenobiotic metabolism (n=5), and unclassified metabolism origins (n=16). Subsequently, we identified 32 druggable proteins expressed in cardiac tissue, which had a directionally concordant association with the identified urinary breakdown products and cardiac outcomes. This included positive control findings, for example higher values of AT1B2 (targeted by digoxin) decreased the risk of HCM, which we were able to link to a novel unclassified urinary breakdown product (X-15497). Additionally, we showed that increased plasma RET values, a mediator of GDF-15 signalling, reduced the risk of HF, and linked this to the novel unclassified urinary breakdown product X-23776. ConclusionWe have identified amino acid, xenobiotic and unclassified metabolism as important pathways contributing to cardiac disease and prioritised 32 druggable proteins as potential therapeutic targets.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Sex-Specific Clinical and Genetic Factors Associated with Adverse Outcomes in Hypertrophic Cardiomyopathy 93%
- Prevalence and disease expression of pathogenic and likely pathogenic variants associated with inherited cardiomyopathies in the general population 93%
- Natural History, Phenotype Spectrum and Clinical Outcomes of Desmin ( DES )-Associated Cardiomyopathy 93%
Similar papers in this journal
- Heart failure, female sex and atrial fibrillation are the main drivers of human atrial cardiomyopathy: results from the CATCH ME consortium 94%
- Development and validation of imaging-free myocardial fibrosis prediction models, association with outcomes, and sample size estimation for phase 3 trials 94%
- Mineralocorticoid Receptor Antagonism Reduces Atrial Arrhythmias Post-Cardiac Surgery and Attenuates Atrial Stress Responses to Cardioplegic Arrest 94%
Similar papers in this journal
- Comparative Analysis of Right Ventricular Metabolic Reprogramming in Pre-clinical Rat Models of Severe Pulmonary Hypertension-induced Right Ventricular Failure 93%
- Fragmented QRS is independently predictive of long-term adverse clinical outcomes in Asian patients hospitalized for heart failure: a retrospective cohort study 93%
- Myofibroblast Ccn3 is regulated by Yap and Wwtr1 and contributes to adverse cardiac outcomes 92%
Similar papers in this journal
- ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel: Reappraisal of Genes associated with Hypertrophic Cardiomyopathy 92%
- Prevalence and clinical importance of titin truncating variants in adults without known congestive heart failure 91%
- Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM Study 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.